Market revenue in 2023 | USD 4.4 million |
Market revenue in 2030 | USD 9.8 million |
Growth rate | 12% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Spain 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
The expansion of major companies in the country is likely to fuel market growth in Spain. For instance, HP, Inc. opened a Digital Manufacturing and 3D Printing Centre of Excellence in Barcelona in 2019, which brought hundreds of the world's leading additive manufacturing experts together.
Another company, in January 2019, Renishaw, a UK-based expert in additive manufacturing, inaugurated a new additive manufacturing solutions center in Barcelona, Spain. Furthermore, increasing number of clinical trials for 3D printed drugs in the region is anticipated to promote market growth.
For instance, in February 2023, The Pharmacy Service at Vall d'Hebron University Hospital will test a 3D printed drug's efficacy, tolerability, and acceptance in children. With the help of a 3D printer, a new formulation can be created to personalize the medication dosage for each patient.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Spain 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account